Edit |   |
---|---|
Antigenic Specificity | Human CD23 |
Clone | [LVNC-4] |
Host Species | Mouse |
Reactive Species | human |
Isotype | IgG1 |
Format | Protein A purified |
Size | 0.1 mg |
Concentration | n/a |
Applications | Flow Cytometry (FC/FACS) |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | CD23 antigen is an integral membrane glycoprotein, Mr. 45 kdaltons The CD23 antigen is present on approximately all pre-B lymphocytes, plasma cells CD25 positive Ki-1 cells and HLA-DR. CD23 antigen is also expressed on Lymphoma, T Cell Lymphomas and B-CLLs. CD23 antigen is present on Hodgkin's and Reed Sternberg cells). |
Immunogen | n/a |
Other Names | [Low affinity immunoglobulin epsilon Fc receptor; Low affinity immunoglobulin epsilon Fc receptor; low affinity immunoglobulin epsilon Fc receptor; Fc fragment of IgE receptor II; BLAST-2; C-type lectin domain family 4 member J; Fc-epsilon-RII; Immunoglobulin E-binding factor; Lymphocyte IgE receptor; CD_antigen: CD23Cleaved into the following 2 chains:Low affinity immunoglobulin epsilon Fc receptor membrane-bound form; Low affinity immunoglobulin epsilon Fc receptor soluble form], [FCER2; FCER2; CD23; FCE2; CD23A; IGEBF; CLEC4J; BLAST-2; CD23A; CLEC4J; FCE2; IGEBF] |
Gene, Accession # | [CD23], Gene ID: 2208, NCBI: P06734.1, UniProt: P06734 |
Catalog # | MBS397636 |
Price | $230 |
Order / More Info | Human CD23 Antibody from MYBIOSOURCE INC. |
Product Specific References | 1. CD23: a multi-lineage cell activation molecule with a split personality. Int J Clin Lab Res 1992; 22(2):73-80Malavasi F; Funaro A; Alessio M; DeMonte LB; Ausiello CM; Dianzani U; Lanza F; Magrini E; Momo M; Roggero S 2. Eleven lymphoid phenotypic markers in HIV infection: selective changes induced by zidovudine treatment. J Acquir Immune Defic Syndr 1992;5(9):890-7Bass HZ; Hardy WD; Mitsuyasu RT; Wang YX; Cumberland W; Fahey JL 3. Three-color cytofluorometric analysis of CD8 cell subsets in HIV-1 infection. J Acquir Immune Defic Syndr 1991;4(12):1227-32 Prince HE; Jensen ER |